Genetic Signatures’ CEO Dr. John Melki in Australia’s Sydney Morning Herald discussing how our technology is helping diagnose COVID-19 patients

A recent article published in Australia’s Sydney Morning Herald with Genetic Signatures’ CEO Dr. John Melki discusses how our novel 3base^TM technology utilised in our EasyScreen^TM SARS-CoV-2 Detection Kit has assisted in the quick diagnosis of the virus amongst patients.

For more on the article click link “It is ultimately saving lives’: Businesses respond to COVID-19 medical supplies plea.”